Concord Drugs Ltd. Live Share Price Today, Share Analysis and Chart

Name: Concord Drugs Ltd.: Is Infosys Ltd. worth buying?
Item: Concord Drugs Ltd.
Rating: 3.13550
Author: Trendlyne DVM scores

Strong Performer

about

62.05 2.93 (4.96%)

56,167

BSE Volume

BSE 29 Aug, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

High Financial Strength

60.0 / 100

Affordable Valuation

58.5 / 100

Technically Bullish

72.3 / 100

Concord Drugs Live Price Chart

Loading Fundamental data..

Loading data..

12 Votes:

Buy 66.67%

Sell 25.0%

Hold 8.33%